The metabolic disorder known as diabetes mellitus (DM) has several different causes, distinguished by recurring hyperglycemia due to inadequate insulin secretion, insulin action, or both. T-lymphocytes target such cells for destruction, which include beta cells. Transplants of the pancreas, islets of Langerhans, and individual beta cells are all effective treatments for DM. Additionally, treating DM using stem cells is popular currently. The basis of stem cell therapy for DM is the replacement of beta cells, or dead pancreatic cells, with stem cells. After attaching to the tissues of the pancreas, the stem cells differentiate into active cells. An X-ray scanner is used to place a catheter into the pancreatic artery in DM, and the process lasts 90 minutes. The use of stem cells to replace dead pancreatic beta cells forms the cornerstone of stem cell treatment for DM. Transplants of the pancreas, islets of Langerhans, and individual beta cells are all effective treatments for insulin-dependent DM.In contrast to prior studies, where we only used low potencies of nosodes and organopreparations, our research used both high and low potencies of these substances. Choosing the strength of the nosode stomach cancer in the computer-connected device selector so that it will resonate with the nosode that is tested in the patient's device is the doctor's responsibility when using the bioresonance therapy method. The initial nosode, which is in the computer programme of the device for bioresonance therapy, is no longer tested when the stomach cancer nosode is tested in a patient along with the chosen potency of this nosode. The initial nosode in the bioresonance therapy device itself is still being studied in case the chosen nosode's potency is inadequate (the frequency of oscillations of the nosode is lower than the frequency of oscillations of the tumour).

Among the most prevalent types of extrapulmonary TB is abdominal (TB). The diagnosis of abdominal TB is difficult. This disorder is thought to be a good imitator of other abdominal illnesses. To reduce morbidity and mortality, early diagnosis, antitubercular medication start-up, and surgical treatment are crucial. Only seldom is surgery necessary because most patients benefit from antitubercular therapy. Imaging is crucial to the diagnosis and care of these individuals. The following patient, aged about 53 years old female, complained of stomach pain, vomiting, loss of appetite, and weight loss when she first arrived. A swollen ileocaecal junction with a cystic lesion was discovered on an ultrasound of the whole abdomen. The patient received antitubercular medication for six months, and she responded favorably to it.